Key facts
- This page summarizes Derek DiRocco's Form 4 filing for 89bio, Inc. (ETNB).
- 1 reported transaction and 1 derivative row are listed below.
- Accepted by SEC: 18 May 2022, 16:09.
Derek DiRocco - 16 May 2022 Form 4 Insider Report for 89bio, Inc. (ETNB)
- Form type
- 4
- Accepted by SEC
- 18 May 2022, 16:09:41 UTC
- Previous filing
- 21 Jun 2021
- Next filing
- 03 Jun 2022
- SEC filing
- View on sec.gov
- Reporting owner signature
- /s/ Ryan A. Murr, as attorney-in-fact for Derek DiRocco
Source evidence
5 source fields
Reporting owner
1 detail
Key filing fact
Derek DiRocco filed Form 4 for 89bio, Inc. (ETNB) on 18 May 2022.
Change
- Previous filing in this sequence was filed on 21 Jun 2021.
- Current net transaction value: $0.
Research use
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Evidence
Filed on Form 4
See Original Filing
Ownership activity is grounded in SEC Form 4 disclosures.
Reported derivative securities
Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.
ETNB
transaction
Derivative
Stock Option (Right to Buy)
Award
- Transaction value
- $0
- Shares
- +25,000
- Change %
- Price
- $0.000000
- Shares after
- 25,000
- Date
- 16 May 2022
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
- 25,000
- Exercise price
- $2.64
- Footnotes
- F1
* marks a reported price that did not pass the local price check.
Additional SEC filing notes
Filing notes and footnotes
Explanation of responses 1 footnote
Footnote F1
This option represents a right to purchase a total of 25,000 shares of the Issuer's Common Stock, which will vest in full on May 16, 2023, subject to the Reporting Person's continued service to the Issuer through such date.